Statement attributed to: David O. Barbe, M.D., President, American Medical Association

"The AMA is pleased the Trump administration is moving forward with its effort to address seemingly arbitrary pricing for prescription drugs. Physicians see the impact of skyrocketing prices every day as patients are often unable to afford the most medically appropriate medications--even those that have effectively controlled their medical condition for years.

"No one can understand the logic behind the high and fluctuating prices. We hope the administration can bring some transparency - and relief - to patients."